| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Angion Biomedica (NASDAQ:ANGN) reported its Q2 earnings results on Monday, August 15, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Angion Biomedica beat estimated earnings by 34.78%, reporting an EPS of $-0.3 versus an estimate of $-0.46.
Revenue was up $113 thousand from the same period last year.
Last quarter the company missed on EPS by $0.05 which was followed by a 6.15% drop in the share price the next day.
Here's a look at Angion Biomedica's past performance:
| Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.43 | -0.62 | -0.72 | -0.69 |
| EPS Actual | -0.48 | 0.58 | -0.53 | -0.58 |
| Revenue Estimate | 920K | 1.74M | 1.06M | 470K |
| Revenue Actual | 1.65M | 25.94M | 1.46M | 540K |
Listen to the earnings announcement yourself by clicking here.
To track all earnings releases for Angion Biomedica visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: ANGN
